Dexamethasone in hospitalised patients with COVID-19: addressing uncertainties

While the data to date confirm the beneficial effects of corticosteroids for critically ill hospitalised patients with COVID-19, commentary discusses some unanswered questions and issues that should be addressed in future research.

The Lancet Respiratory Medicine